Table 1.
Pre- and perioperative characteristics of 677 patients with laser enucleation of the prostate from the University Hospital Frankfurt between 11/2017 and 01/2022, stratified according to surgeon’s caseload
| N | Overall, N = 677a | Caseload < 25, N = 84 (12%)a | Caseload 25–49, N = 75 (11%)a | Caseload 50–99, N = 82 (12%)1 | Caseload 100–199, N = 106 (16%)a | Caseload > = 200, N = 330 (49%)a | p valueb | |
|---|---|---|---|---|---|---|---|---|
| Age [years] | 676 | 69 (63, 76) | 69 (64, 76) | 68 (62, 75) | 70 (64, 76) | 70 (64, 76) | 69 (64, 75) | 0.7 |
| PSA [ng/ml] | 567 | 4.3 (2.4, 8.1) | 4.2 (2.2, 7.3) | 4.3 (2.6, 7.2) | 4.7 (2.5, 8.6) | 5.3 (3.4, 10.4) | 4.1 (2.2, 7.8) | 0.2 |
| TRUS [ccm] | 670 | 79 (55, 101) | 67 (50, 90) | 66 (54, 86) | 82 (51, 100) | 80 (62, 110) | 80 (55, 109) | 0.009 |
| OR time [min] | 675 | 73 (51, 107) | 111 (91, 140) | 108 (72, 128) | 89 (66, 133) | 80 (60, 100) | 55 (43, 76) | < 0.001 |
| Enucleation volume [g] | 673 | 55 (30, 82) | 54 (26, 70) | 45 (26, 75) | 51 (27, 68) | 60 (38, 90) | 58 (33, 85) | 0.03 |
| Catheter time [days] | 652 | 2.0 (2.0, 2.0) | 2.0 (2.0, 2.0) | 2.0 (2.0, 2.0) | 2.0 (2.0, 2.0) | 2.0 (2.0, 2.0) | 2.0 (2.0, 2.0) | 0.3 |
| ASA status | 676 | 0.3 | ||||||
| I/II | 452 (67%) | 53 (63%) | 48 (65%) | 49 (60%) | 68 (64%) | 234 (71%) | ||
| III/IV | 224 (33%) | 31 (37%) | 26 (35%) | 33 (40%) | 38 (36%) | 96 (29%) | ||
| preOP transurethral catheter (n,%) | 614 | 215 (35%) | 35 (44%) | 28 (42%) | 28 (39%) | 38 (37%) | 86 (29%) | 0.07 |
Bold values indicate the p-values represent significant values (p < 0.05)
PSA prostate-specific antigen; TRUS prostate volume in transrectal ultrasound; OR operating room; ASA American Society of Anesthesiologists Physical Status Classification System
aMedian (Interquartile range IQR); n (%)
bKruskal−Wallis rank sum test; Pearson’s Chi-square test